Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use—A Narrative Review
Preprint
- 30 April 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The spread of antimicrobial resistance (AMR) is a global challenge. Close and continuous surveillance for quick detection of AMR can be difficult, especially in remote places. This narrative review focuses on the contributions of pharmacovigilance (PV) as an auxiliary tool for identifying and monitoring the ineffectiveness of, resistance to, and inappropriate use of antibiotics (ABs). The terms “drug ineffective,” “therapeutic failure,” “drug resistance,” “pathogen resistance,” and “multidrug resistance” were found in PV databases and dictionnaires, and denote ineffectiveness. These terms cover a range of problems that should be better investigated because they are useful in warning about possible causes of AMR. “Medication errors,” especially those related to dose and indication, are highlighted in the literature, suggesting inappropriate use of ABs. Hence, the included studies show that the terms of interest related to AMR are not only present but frequent in PV surveillance programs. This review illustrates the feasibility of using PV as a complementary tool for antimicrobial stewardship activities, especially in scenarios where other resources are scarce.Keywords
All Related Versions
- Version 1, 2024-04-30, Preprints
- Published version: Antibiotics, 13 (5), 457.
This publication has 123 references indexed in Scilit:
- Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactionsPharmacology Research & Perspectives, 2022
- Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistancePharmacoepidemiology and Drug Safety, 2021
- Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance databaseEuropean Journal of Clinical Pharmacology, 2021
- Antimicrobial stewardship: can we add pharmacovigilance networks to the toolbox?European Journal of Clinical Pharmacology, 2020
- Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysisEuropean Journal of Clinical Pharmacology, 2020
- Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactionsPharmacoepidemiology and Drug Safety, 2019
- Increased risk for aseptic meningitis after amoxicillin or amoxicillin‐clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactionsPharmacoepidemiology and Drug Safety, 2018
- Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19–22 August 2010, Brighton, UKPharmacoepidemiology and Drug Safety, 2010
- Adverse drug reactions and off‐label prescribing for paediatric outpatients: a one‐year survey of spontaneous reports in SwedenPharmacoepidemiology and Drug Safety, 2003